The Bazelet Group is the largest medical cannabis company in Israel, serving monthly 9,000 patients, which are nearly one half of the licensed users.
Bazelet processes the cannabis grown by four out of the eight legal farms in Israel. Bazelet products include cannabis buds in sealed barcoded packages, flowers ground in a proprietary method resulting in a product of unique quality, special cannabis cigarettes, cannabis extracts, vaporizer tablets, sustained-release capsules, topicals and suppositories. Additionally, Bazelet’s operations include secure delivery to 7,500 homes every month, educating newly licensed users (15,000 over the last 3 years), guiding and providing strain-selection advice to thousands of clients and operating a sophisticated call center.
Bazelet is constructing a new GMP plant with the capacity to serve 100,000 patients. Bazelet is also developing new technologies in various fields, including new delivery methods, vaporizers and veterinary applications.
Bazelet’s experience and production knowledge, frequent feedback from thousands of clients and dedicated science are combined in order to lead the cannabis industry in product quality, precision, cost reduction and serving the needs of special populations, such as epileptic children and patients in nursing homes or geriatric hospitals.
The Bazelet Group was founded five years ago in order to meet the biggest need of the legal cannabis industry at the time – securing the cannabis farms. As the number of licensed patients increases, so do the needs that must be met, including processing, delivering agricultural products to the manufacturing plant and from there to the client, storage, education and guidance, improved delivery systems, etc. Bazelet grew to address these needs.
Bazelet Nehushtan has constructed a unique and modern plant and a logistic center according to the needs of patients and farms, using the company’s ever-growing experience. The recently approved new Israeli regulation adds more demands on the one hand, and will drastically increase the number of patients on the other. Bazelet Nehushtan’s next GMP plant is designed to address these needs and opportunities.
Bazelet Pharma is in charge of best employing and further improvement of the years-long Intimate knowledge and experience with thousands of patients: education and Instruction of newly licensed users for best use, addressing patients’ difficulties and guiding them in strain selection. Bazelet Pharma maintains the group’s call-center and is in charge of the secure delivery to patient homes (450,000 deliveries in recent years).
Bazelet KnowHow is tasked with implementing Bazelet Nehushtan and Bazelet Pharma’s know-how in other countries where medical cannabis was approved or will soon be approved.
Bazelet Technologies is the group’s technology incubator, where new products and new technologies are developed. This, so far self-funded R&D effort, has led to filing of 35 provisional patent applications, 2 of them have been granted (USA) and another 25 are in the PCT stage. Some of our recent results are exciting and highly promising.
Whether you are an investor, grower, physician or pharmacist, Bazelet offers a wide range of collaboration opportuni-ties!